PacBio has announced a new study published in Nature Communications that presents an innovative method for analyzing complex regions of the human genome, particularly segmental duplications that have ...
PacBio's Advanced Sequencing Solutions Enable Breakthrough in Understanding Rare Mendelian Condition
PacBio announced its involvement in a groundbreaking study published in Nature Genetics, which utilized its advanced sequencing technology to explore the genetic basis of a rare Mendelian condition in ...
Zacks Investment Research on MSN
PacBio expands HiFi sequencing reach with new SPRQ-Nx technology
PacBio PACB recently announced the worldwide commercial availability of its SPRQ-Nx sequencing chemistry and new multi-use ...
Paraphase Enables Researchers to Analyze Genes That are Critically Relevant but Hard to Genotype MENLO PARK, Calif., March 14, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of highly ...
MENLO PARK, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced the results of a study published ...
MENLO PARK, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally ...
Pacific Biosciences of California, Inc. (NASDAQ:PACB) is at the forefront of long-read sequencing technology, which maps the entire genome using longer DNA segments. Despite the completion of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results